The AmLaw Litigation Daily highlighted Finnegan attorneys Charles Lipsey, John Livingstone, Jill MacAlpine, David Weingarten, Ryan O’Quinn, Matt Hlinka, and Megan Meyers for their District of Delaware bench trial win on behalf of client AstraZeneca. The ruling protected AstraZeneca’s FARXIGA drug products against generic competition, stating the opposition failed to prove AstraZeneca’s patent claims were invalid due to obviousness.
Press Release
October 6, 2026
Award/Ranking
Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027
September 24, 2026
Commentary
FORUM IP Talks: Dr. Jochen Herr on UPC, FRAND, and Cross-Border Enforcement Topics
September 20, 2026
Commentary
Uncrustables Fame Ruling Sets Up Functionality Fight Over Crimped Edge
September 11, 2026
Award/Ranking
September 11, 2026
Media Mention
Finnegan Opens First Texas Office with ‘Two Leaders with Genuine Local Roots'
September 7, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.